J Korean Med Sci.  2020 Dec;35(47):e409. 10.3346/jkms.2020.35.e409.

Brief Communication

• Park HY
• Jung J
• Park HY
• Lee SH
• Kim ES
• Kim HB
• Song KH

• KMID: 2509447
• DOI: http://doi.org/10.3346/jkms.2020.35.e409

Abstract

As the coronavirus disease 2019 (COVID-19) has rapidly spread worldwide, there are growing concerns about patients' mental health. We investigated psychological problems in COVID-19 patients assessed with self-reported questionnaires including the Patient Health Questionnaire-9, Generalized Anxiety Disorder-7 scale, and Impact of Event ScaleRevised Korean version. Ten patients who recovered from COVID-19 pneumonia without complications underwent self-reported questionnaires about 1 month after discharge. Of them, 10% reported depression and posttraumatic stress disorder (PTSD) while 50% had depression during the treatment. Perceived stigma and history of psychiatric treatment affected PTSD symptom severity, consistent with previous emerging infectious diseases. Survivors also reported that they were concerned about infecting others and being discriminated and that they chose to avoid others after discharge. Further support and strategy to minimize their psychosocial difficulties after discharge should be considered.

Keyword

COVID-19; SARS-CoV-2; Depression; PTSD; Survivor; Pneumonia

Reference

1. World Health Organization (WHO). Novel coronavirus (2019-nCoV) situation reports. Updated 2020. Accessed June 9, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.

2. Cheng SK, Wong CW, Tsang J, Wong KC. Psychological distress and negative appraisals in survivors of severe acute respiratory syndrome (SARS). Psychol Med. 2004; 34(7):1187–1195. PMID: 15697045.

3. Park HY, Park WB, Lee SH, Kim JL, Lee JJ, Lee H, et al. Posttraumatic stress disorder and depression of survivors 12 months after the outbreak of Middle East respiratory syndrome in South Korea. BMC Public Health. 2020; 20(1):605. PMID: 32410603.

4. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606–613. PMID: 11556941.

5. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092–1097. PMID: 16717171.

6. Lim HK, Woo JM, Kim TS, Kim TH, Choi KS, Chung SK, et al. Reliability and validity of the Korean version of the Impact of Event Scale-Revised. Compr Psychiatry. 2009; 50(4):385–390. PMID: 19486738.

7. Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001; 24(6):518–529. PMID: 11746080.

8. Wiklander M, Rydström LL, Ygge BM, Navér L, Wettergren L, Eriksson LE. Psychometric properties of a short version of the HIV stigma scale, adapted for children with HIV infection. Health Qual Life Outcomes. 2013; 11:195. PMID: 24225077.

9. Sim M. Psychological trauma of Middle East respiratory syndrome victims and bereaved families. Epidemiol Health. 2016; 38:e2016054. PMID: 27919121.

10. Lee S, Chan LY, Chau AM, Kwok KP, Kleinman A. The experience of SARS-related stigma at Amoy Gardens. Soc Sci Med. 2005; 61(9):2038–2046. PMID: 15913861.

11. Siu JY. The SARS-associated stigma of SARS victims in the post-SARS era of Hong Kong. Qual Health Res. 2008; 18(6):729–738. PMID: 18503014.